Pfizer Eyes Resuming Phase III Enrollment, Investigates Phase Ib Death Tied to Duchenne Muscular Dystrophy Candidate

Human Gene Therapy,Volume 33, Issue 5-6, Page 215-217, March 2022.

Source: Human Gene Therapy - March 16, 2022 Category: Genetics & Stem Cells Authors: Alex Philippidis Source Type: research